3Report of Expert Committee on the diagnosis and classification of diabetes mellitus[J]. Diabetes Care ,2001,24 ( Suppl 1 ) :5-20.
4King H, Aubert RE, Herman WH. Global burden of diabetes, 1995- 2025 : prevalence, numerical estimates, and projeetions [ J ]. Diabetes Care, 1998,21 (9) : 14142-4311.
5Shaw JE, Zimmet PZ, de Courten M, et al. Impaired fasting glucose or imparited glucose tolerance. What best predicts future diabetes in Mauritius? [J]. Diabetes Care,1999,22(3) :399-402.
6Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women[ J]. Diabetes ,2002,5 (9) :2796-2803.
7UK Prospective Diabetes Study (UKPDS) Group. Intensive Bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33 ) [J]. Lancet, 1998,352 (9131) :837-853.
8DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria [ J ]. Arch Intern Med, 2001,161 (3) :397-405.
9Bonora E, Kiechl S, Oberhollenzer F, et al. Impaired glucose tolerance,Type Ⅱ diabetes mellitus and carotid atherosclerosis: prospective resuits from the Bruneck Study[J]. Diabetologia,2000,43 C2) :156-164.
10Saydah SH, Loria CM, Eberhardt MS, et al. Subclinical states of glucose intolerance and risk of death in the U. S [ J ]. Diabetes Care ,2001,24(3 ) :447-453.
